ResMed Inc. (RMD) is a leading global manufacturer of high-quality medical devices and software solutions that cater mainly to sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. With its motto, "Changing lives with every breath," the company is primarily known for its innovative technology that assists in diagnosing and treating these conditions.
Founded in 1989 and headquartered in San Diego, California, ResMed has progressed enormously since its inception. Peter C. Farrell, Ph.D., founded the company with a clear vision to help millions of people worldwide breathe and sleep better. The company now employs over 7500 people globally and manages a direct presence in more than 140 countries.
ResMed's influential range of products include devices, masks, as well as entire connected care systems. Globally recognized for its continuous positive airway pressure (CPAP) devices, ResMed also offers other effective solutions such as sleep diagnostics tools, ventilation devices, and an innovative digital health platform. This platform facilitates cloud-connectivity for devices, enabling physicians and patients to monitor disease progression and therapy outcomes remotely, enhancing overall patient care.
The company has consistently prioritized research and development, investing significantly into designing innovative solutions that improve patients' health. Their inventions have not only served patients but also benefited home medical equipment suppliers, hospitals, and health insurance companies that must efficiently manage these serious, chronic diseases.
ResMed Inc. has been listed on the New York Stock Exchange and Australian Securities Exchange (ASX) since 1995, under the ticker RMD. The company has shown remarkable financial performance over the years, demonstrating stable growth and robust profitability.
ResMed's core strategy revolves around promoting a value-based healthcare system, as it believes in the concept of improving lives and reducing healthcare system costs. The company provides robust digital health solutions that transform the patient treatment journey, from hospital to home, enhancing their quality of life.
Gracious in its success, ResMed has also committed to social responsibility initiatives, focusing on minimizing environmental impacts, upholding strong business ethics, and fostering diversity and inclusion.
In conclusion, ResMed Inc. (RMD) has established a strong legacy in addressing and managing respiratory conditions. By pursuing innovation, digital transformation, research, and development, it continues to change lives globally by fulfilling its mission of a world without sleep-disordered breathing.